Condition (MeSH)
Glycosuria, Renal
ClinicalTrials.gov lists 2 trials for Glycosuria, Renal or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Rows recorded per section
4 sections measured, none recorded · 1 not measured yet · 1 not computed
2 of the 2 trials are tagged with Glycosuria, Renal itself; the rest are tagged with a narrower condition beneath it.
When did Glycosuria, Renal trials start? (2)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
| Year | Trials started |
|---|---|
| 2019 | 1 |
| 2009 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 2 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Glycosuria, Renal trials in? (1)
Shown in this order: phase order.
| Phase | Trials |
|---|---|
| Observational | 2 |
How many Glycosuria, Renal trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which publications cover Glycosuria, Renal? (4)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Molecular analysis of the SGLT2 gene in patients with renal glucosuria. | Journal of the American Society of Nephrology : JASN | 2003 | Yes |
| Autosomal recessive renal glucosuria attributable to a mutation in the sodium glucose cotransporter (SGLT2). | Human genetics | 2002 | Yes |
| [Sodium-glucose co-transporter-2 inhibitors: from the bark of apple trees and familial renal glycosuria to the treatment of type 2 diabetes mellitus]. | Medicina clinica | 2013 | No |
| Role of sodium-glucose cotransporter 2 (SGLT 2) inhibitors in the treatment of type 2 diabetes. | Endocrine reviews | 2011 | No |
Prevalence (1)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Familial renal glucosuria | Point prevalence | Unknown | Worldwide | Not stated | Unspecified |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.